Strong Launches Will Help BMS Win The LOE Battle In 2023 And Beyond
Three New Drugs Reached US Market In 2022
Bristol Myers Squibb brought the last of nine new drugs to market last year – all needed to help it overcome three big losses of exclusivity this decade – so the focus this year is commercial execution.
